Ethyl 4-bromo-3,5-diethoxybenzoate, 95.0%, 250mg

Furo[3,2-c]pyridin-4(5H)-one, 97.0%, 250mg

(9H-Fluoren-9-yl)methyl (2-(2-(2-aminoethoxy)ethoxy)ethyl)carbamate hydrochloride, 95%, 1g

(S)-3-(4-ACETYLPHENYL)-2-AMINOPROPANOIC ACID HCL, 95.0%, 5g

(R)-2-((tert-Butoxycarbonyl)amino)-3-hydroxy-2-methylpropanoic acid, 95.0%, 250mg

N-(5-METHYL-2-OXO-2,3-DIHYDROPYRIMIDIN-4-YL)BENZAMIDE, 95.0%, 250mg

D(+)-10-Camphorsulfonyl chloride, tech, 5g

Hydroxyde de sodium, min 98 %, pa, ISO, en pastilles, 2,5 kg, emballage plastique.

(4,6-dimethylpyrimidin-2-yl)cyanamide, 250mg

tert-Butyl 3-(dimethylamino)piperidine-1-carboxylate, 95+%, 1g

(5-Bromo-2-(trifluoromethyl)pyridin-4-yl)methanol, 95.0%, 250mg

(1R,2R)-2-((TERT-BUTOXYCARBONYL)AMINO)CYCLOPROPANECARBOXYLIC ACID, 95.0%, 25mg

7-BOC-3-OXOHEXAHYDROIMIDAZO[1,5-A]PYRAZINE, 97.0%, 1g